Asylia Therapeutics, Inc.

0 followers


Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases.The company's platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has produced unprecedented anti-tumor response... Read more

Employees

1-10

Links


Org chart

Richard Jones, Ph.D.
Director Translational Biology
Collapse
John Miller
Senior Principal Scientist
Parth Mangrolia, PhD
Senior Scientist, Preclinical Development

Teams

This company has no teams yet